Oh Moeras matchmaker bep chemo recovery time slogan middernacht Verplicht
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report | Journal of Medical Case Reports | Full Text
A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) - ScienceDirect
Effects of BEP treatment at 9 wk and following a 9-wk recovery period... | Download Scientific Diagram
Patient-Reported Outcomes for Testicular Cancer Treatments | PROM
Testicular Cancer Stories: Non-Seminoma Germ Cell, Stage 3C - The Patient Story
Late adverse effects and quality of life in survivors of testicular germ cell tumour | Nature Reviews Urology
The First Week of Chemotherapy | A Ballsy Sense of Tumor
Testicular Germ-Cell Tumors: A History of “If You Don't Cure the First Time, Try, Try Again”
Testicular Germ-Cell Tumors: A History of “If You Don't Cure the First Time, Try, Try Again”
BEP Chemotherapy: What to Expect | A Ballsy Sense of Tumor
Transient effects of chemotherapy for testicular cancer on mouse behaviour | Scientific Reports
Transient effects of chemotherapy for testicular cancer on mouse behaviour | Scientific Reports
Chemotherapy - Wikipedia
Patient-Reported Outcomes for Testicular Cancer Treatments | PROM
IJMS | Free Full-Text | Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility | HTML
PDF) Transient effects of chemotherapy for testicular cancer on mouse behaviour
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
BEP Chemotherapy: What to Expect | A Ballsy Sense of Tumor
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG,
Fertility managment in testicular cancer: the need to establish a standardized and evidence‐based patient‐centric pathway - Moody - 2019 - BJU International - Wiley Online Library